松澤文彦 医師（JCHO札幌北辰病院）の論文が BMC Cancer 誌に掲載されました。
2021/03/01
お知らせ
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Matsuzawa F, Kamachi H, Mizukami T, Einama T, Kawamata F, Fujii Y, Fukai M, Kobayashi N, Hatanaka Y, Taketomi A.
BMC Cancer. 2021 Feb 26;21(1):200. doi: 10.1186/s12885-020-07722-3.